Clinical Trial Update: Carbon Dioxide Insufflation on Cerebral Microemboli [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating carbon dioxide insufflation to reduce cerebral microemboli in patients with cardiovascular disease and mitral valve disease w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Cerebral Microemboli
• Cognitive Decline
• Mitral Valve Disease

Snippet

Sponsor: University Health Network, Toronto | Conditions: Cardiovascular Disease, Mitral Valve Repair | Phase 2, Phase 3 | Status: TERMINATED